146 Rimonabant PPTs View free & download

Changes in weight and waist size in the rimonabant- and placebo-treated groups PowerPoint PPT Presentation

Changes in weight and waist size in the rimonabant- and placebo-treated groups - Changes in weight and waist size in the rimonabant- and placebo-treated groups p Placebo (n=348) Rimonabant 20 mg (n=339) End point

Changes in weight and waist size in the rimonabant- and placebo-treated groups p Placebo (n=348) Rimonabant 20 mg (n=339) End point

| PowerPoint PPT presentation | free to download

Rimonabant: New therapeutic option for managing cardiometabolic risk PowerPoint PPT Presentation

Rimonabant: New therapeutic option for managing cardiometabolic risk - Increased prevalence of these conditions is projected to have a major impact on ... (CB2) Cannabinoid receptor type 1 (CB1) Immune cells. Most widespread CB receptor ...

Increased prevalence of these conditions is projected to have a major impact on ... (CB2) Cannabinoid receptor type 1 (CB1) Immune cells. Most widespread CB receptor ...

| PowerPoint PPT presentation | free to view

STRADIVARIUS Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesi PowerPoint PPT Presentation

STRADIVARIUS Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesi - PAV: primary endpoint. TAV: secondary endpoint -2.2. 0.88. 0.51. 0.25. P 0. ... for rimonabant on the primary endpoint, PAV (P = 0.22), but a favorable effect ...

PAV: primary endpoint. TAV: secondary endpoint -2.2. 0.88. 0.51. 0.25. P 0. ... for rimonabant on the primary endpoint, PAV (P = 0.22), but a favorable effect ...

| PowerPoint PPT presentation | free to view

Sesin Bibliogrfica 2513 Rimonabant un bloqueante de los receptores de canabinoides1 y dieta inducen PowerPoint PPT Presentation

Sesin Bibliogrfica 2513 Rimonabant un bloqueante de los receptores de canabinoides1 y dieta inducen - Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J. Effect of ... de rimonabant a placebo volvieron a ganar peso, mientras que los que siguieron ...

Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J. Effect of ... de rimonabant a placebo volvieron a ganar peso, mientras que los que siguieron ...

| PowerPoint PPT presentation | free to view

Presentazione di PowerPoint PowerPoint PPT Presentation

Presentazione di PowerPoint - ... 299:1547-60 Effects of Rimonabant on Body Weight, Waist Circumference, and Levels of HDL-C, Triglycerides, Fasting Insulin, and Glycated Hemoglobin ...

... 299:1547-60 Effects of Rimonabant on Body Weight, Waist Circumference, and Levels of HDL-C, Triglycerides, Fasting Insulin, and Glycated Hemoglobin ...

| PowerPoint PPT presentation | free to download

Clinical evaluation of CB1 receptor blockade PowerPoint PPT Presentation

Clinical evaluation of CB1 receptor blockade - Clinical evaluation of CB1 receptor blockade Rimonabant clinical trial program Rimonabant In Obesity (RIO) program RIO program: Improved cardiometabolic risk factors ...

Clinical evaluation of CB1 receptor blockade Rimonabant clinical trial program Rimonabant In Obesity (RIO) program RIO program: Improved cardiometabolic risk factors ...

| PowerPoint PPT presentation | free to download

Presentazione di PowerPoint - ... 353: 2121-34 Effect of Placebo or 20 mg of Rimonabant for 52 Weeks on the Plasma Glucose and Insulin Responses to Oral Glucose Challenge (Panels A - B), ...

... 353: 2121-34 Effect of Placebo or 20 mg of Rimonabant for 52 Weeks on the Plasma Glucose and Insulin Responses to Oral Glucose Challenge (Panels A - B), ...

| PowerPoint PPT presentation | free to download

Cannabinoid CB1 receptor PowerPoint PPT Presentation

Cannabinoid CB1 receptor - ... Highest conc in hippo, striatum, ctx and cerebellum THC acts as CB1 agonist Some diet drugs act as CB1 antagonist Rimonabant (aka SR141716) ...

... Highest conc in hippo, striatum, ctx and cerebellum THC acts as CB1 agonist Some diet drugs act as CB1 antagonist Rimonabant (aka SR141716) ...

| PowerPoint PPT presentation | free to download

Catheter Ablation for the Cure of Atrial Fibrillation Study PowerPoint PPT Presentation

Catheter Ablation for the Cure of Atrial Fibrillation Study - Among patients with paroxysmal or persistent atrial fibrillation who have already failed antiarrhythmic ... with antiarrhythmic drug ... Rimonabant in Obesity ...

Among patients with paroxysmal or persistent atrial fibrillation who have already failed antiarrhythmic ... with antiarrhythmic drug ... Rimonabant in Obesity ...

| PowerPoint PPT presentation | free to download

Diapositive 1 PowerPoint PPT Presentation

Diapositive 1 - R duire les dommages de l'hyperglyc mie. R duire les autres facteurs ... ANTAGONISTES DES RECEPTEURS CB1. Rimonabant. Effets centraux. Effets p riph riques. Prise ...

R duire les dommages de l'hyperglyc mie. R duire les autres facteurs ... ANTAGONISTES DES RECEPTEURS CB1. Rimonabant. Effets centraux. Effets p riph riques. Prise ...

| PowerPoint PPT presentation | free to download

Data Supplement PowerPoint PPT Presentation

Data Supplement - Arthralgia. 9. Dizziness. 12. Nasopharyngitis. 12. Nausea. Rimonabant 20 mg (%) (n = 339) ... Arthralgia. 11.2. Nausea. 17.0. Nasopharyngitis. 18.5. URTI ...

Arthralgia. 9. Dizziness. 12. Nasopharyngitis. 12. Nausea. Rimonabant 20 mg (%) (n = 339) ... Arthralgia. 11.2. Nausea. 17.0. Nasopharyngitis. 18.5. URTI ...

| PowerPoint PPT presentation | free to view

Diabetes Primary Care Study Day New NICE Guidance on Lipids: General 67 and Diabetes 66 Wiltshire Mu PowerPoint PPT Presentation

Diabetes Primary Care Study Day New NICE Guidance on Lipids: General 67 and Diabetes 66 Wiltshire Mu - Rimonabant. NNTs. JBS2 - targets. Total Cholesterol 4 and. LDL Cholesterol 2. OR ... Limits cholesterol absorption by specific effect on transport. Few side-effects ...

Rimonabant. NNTs. JBS2 - targets. Total Cholesterol 4 and. LDL Cholesterol 2. OR ... Limits cholesterol absorption by specific effect on transport. Few side-effects ...

| PowerPoint PPT presentation | free to view

Patients views PowerPoint PPT Presentation

Patients views - Patients prescribed either orlistat, sibutramine, rimonabant in the last 2 years ... loss in the short-term adapted to medication regime & managed side effects ' ...

Patients prescribed either orlistat, sibutramine, rimonabant in the last 2 years ... loss in the short-term adapted to medication regime & managed side effects ' ...

| PowerPoint PPT presentation | free to view

Weight loss tablets PowerPoint PPT Presentation

Weight loss tablets - Find weight loss tablets with affordable price.

Find weight loss tablets with affordable price.

| PowerPoint PPT presentation | free to download

Presentazione di PowerPoint - Title: Presentazione di PowerPoint Author: Walter Fratta Last modified by: Engius Created Date: 5/23/2002 4:29:51 PM Document presentation format

Title: Presentazione di PowerPoint Author: Walter Fratta Last modified by: Engius Created Date: 5/23/2002 4:29:51 PM Document presentation format

| PowerPoint PPT presentation | free to download

Data Supplement - Data Supplement RIO-Europe RIO-Lipids RIO-Diabetes RIO-North America European labeling

Data Supplement RIO-Europe RIO-Lipids RIO-Diabetes RIO-North America European labeling

| PowerPoint PPT presentation | free to view

Pharmacy Dropship PowerPoint PPT Presentation

Pharmacy Dropship - Best Pharmcy Dropshiping services from india.

Best Pharmcy Dropshiping services from india.

| PowerPoint PPT presentation | free to download

Journal Club PowerPoint PPT Presentation

Journal Club - Biliopancreatic diversion Roux-en-Y gastric bypass Sleeve gastrectomy with duodenal switch Adjustable gastric banding ... laparoscopic adjustable gastric ...

Biliopancreatic diversion Roux-en-Y gastric bypass Sleeve gastrectomy with duodenal switch Adjustable gastric banding ... laparoscopic adjustable gastric ...

| PowerPoint PPT presentation | free to download

Obesity Treatment Pyramid PowerPoint PPT Presentation

Obesity Treatment Pyramid - The Practical Guide: Identification, Evaluation, and Treatment of Overweight and ... Exenatide (Byetta); incretin mimetic. Enhances insulin secretion ...

The Practical Guide: Identification, Evaluation, and Treatment of Overweight and ... Exenatide (Byetta); incretin mimetic. Enhances insulin secretion ...

| PowerPoint PPT presentation | free to view

Top 10 Cannabis Based Pharmaceutical Drugs PowerPoint PPT Presentation

Top 10 Cannabis Based Pharmaceutical Drugs - Medical marijuana comes in many different forms. You may be surprised to know that there is various cannabis based pharmaceutical drugs in the market.

Medical marijuana comes in many different forms. You may be surprised to know that there is various cannabis based pharmaceutical drugs in the market.

| PowerPoint PPT presentation | free to download

Cannabinoid CB1 ligands PowerPoint PPT Presentation

Cannabinoid CB1 ligands - Cannabinoid CB1 ligands. LY 320135. CB1 antagonist. AM251. CB1 ... Acomplia, CB1 antagonist. CP-55940. Mixed CB1/CB2 agonist. HU-210. Mixed CB1/CB2 agonist ...

Cannabinoid CB1 ligands. LY 320135. CB1 antagonist. AM251. CB1 ... Acomplia, CB1 antagonist. CP-55940. Mixed CB1/CB2 agonist. HU-210. Mixed CB1/CB2 agonist ...

| PowerPoint PPT presentation | free to view

Diet%20Pills PowerPoint PPT Presentation

Diet%20Pills - Diet Pills. By Cathy Chang. Article ... and suicide in patients taking the diet pill. ... Why do you think that people would prefer to take diet pills? ...

Diet Pills. By Cathy Chang. Article ... and suicide in patients taking the diet pill. ... Why do you think that people would prefer to take diet pills? ...

| PowerPoint PPT presentation | free to download

Managing HbA1c and CRP in a hypertensive diabetic patient PowerPoint PPT Presentation

Managing HbA1c and CRP in a hypertensive diabetic patient - ... New therapies GLP1 analogs Exenitide GLP1-degradation blockers Dipeptidyl peptidase 4 (DPP4) inhibitors Sitagliptin Vildagliptin Weight and diabetes: ...

... New therapies GLP1 analogs Exenitide GLP1-degradation blockers Dipeptidyl peptidase 4 (DPP4) inhibitors Sitagliptin Vildagliptin Weight and diabetes: ...

| PowerPoint PPT presentation | free to view

Marco Lo Dico Ugo Perricone PowerPoint PPT Presentation

Marco Lo Dico Ugo Perricone - Etat caract ris par un exc s de masse adipeuse repartie de fa on g n ralis e ... En agissant sur les canaux du calcium, donc sur la concentration du Ca ...

Etat caract ris par un exc s de masse adipeuse repartie de fa on g n ralis e ... En agissant sur les canaux du calcium, donc sur la concentration du Ca ...

| PowerPoint PPT presentation | free to view

Obesity Treatment Pyramid - Obesity Treatment Pyramid Surgery Pharmacotherapy Lifestyle Modification Diet Physical Activity Guide for Selecting Obesity Treatment Obesity and Dietary Therapy ...

Obesity Treatment Pyramid Surgery Pharmacotherapy Lifestyle Modification Diet Physical Activity Guide for Selecting Obesity Treatment Obesity and Dietary Therapy ...

| PowerPoint PPT presentation | free to view

ACTIVE PHARMACEUTICAL INGREDIENTS FROM DEV LIFE CORPORATION PowerPoint PPT Presentation

ACTIVE PHARMACEUTICAL INGREDIENTS FROM DEV LIFE CORPORATION - ... asthmatic / bronchodilator montelukast sodium roflumilast salmeterol xinafoate zafirlukast anti hypertensive eplerenone ... powerpoint presentation ...

... asthmatic / bronchodilator montelukast sodium roflumilast salmeterol xinafoate zafirlukast anti hypertensive eplerenone ... powerpoint presentation ...

| PowerPoint PPT presentation | free to download

MEDICAL MANAGEMENT OF OBESITY Selected Topics PowerPoint PPT Presentation

MEDICAL MANAGEMENT OF OBESITY Selected Topics - MEDICAL MANAGEMENT OF OBESITY Selected Topics Patient evaluation Diet Exercise Obesity medications * CNTF: endogenous neuroprotective factor in Schwann cells and ...

MEDICAL MANAGEMENT OF OBESITY Selected Topics Patient evaluation Diet Exercise Obesity medications * CNTF: endogenous neuroprotective factor in Schwann cells and ...

| PowerPoint PPT presentation | free to download

Dyslipidemia in the Metabolic Syndrome: Can 1 agent treat all? PowerPoint PPT Presentation

Dyslipidemia in the Metabolic Syndrome: Can 1 agent treat all? - Dyslipidemia in the Metabolic Syndrome: Can 1 agent treat all? Brian Tulloch, M.D. Diagnostic Clinic Houston, Texas

Dyslipidemia in the Metabolic Syndrome: Can 1 agent treat all? Brian Tulloch, M.D. Diagnostic Clinic Houston, Texas

| PowerPoint PPT presentation | free to download

St - 1988 High-affinity cannabinoid binding sites were discovered in rat brain ... Inhibition of neurotransmitter release is blocked by antagonists of CB1 receptor. ...

1988 High-affinity cannabinoid binding sites were discovered in rat brain ... Inhibition of neurotransmitter release is blocked by antagonists of CB1 receptor. ...

| PowerPoint PPT presentation | free to view

Obesity : the new health issue Overview of therapeutics in the area Dr Richard Palmer CEO and R PowerPoint PPT Presentation

Obesity : the new health issue Overview of therapeutics in the area Dr Richard Palmer CEO and R - Prevalence of Adult Obesity in Europe BMI 30 Kgm2 ... Insulin enhancer. Pramlintide. Alizyme. Lipase inhibitor. Cetilistat. Sanofi-Aventis. CB1 antagonist ...

Prevalence of Adult Obesity in Europe BMI 30 Kgm2 ... Insulin enhancer. Pramlintide. Alizyme. Lipase inhibitor. Cetilistat. Sanofi-Aventis. CB1 antagonist ...

| PowerPoint PPT presentation | free to view

Abdominal Obesity and Cardiometabolic Risk: The Role of the Endocannabinoid System PowerPoint PPT Presentation

Abdominal Obesity and Cardiometabolic Risk: The Role of the Endocannabinoid System - Gout. Cholecystitis. Colon (?Breast) Cancers ... Gout. Gall Bladder. Disease. Some Cancers. What Is Cardiometabolic Risk? Diabetes: A Genetic Legacy ...

Gout. Cholecystitis. Colon (?Breast) Cancers ... Gout. Gall Bladder. Disease. Some Cancers. What Is Cardiometabolic Risk? Diabetes: A Genetic Legacy ...

| PowerPoint PPT presentation | free to view

Obesity - Biochemistry

Biochemistry

| PowerPoint PPT presentation | free to download

of atherosclerosis in patients with abdominal obesity an PowerPoint PPT Presentation

of atherosclerosis in patients with abdominal obesity an - of atherosclerosis in patients with abdominal obesity and coronary artery disease ... Abdominal obesity is associated with specific metabolic abnormalities that ...

of atherosclerosis in patients with abdominal obesity and coronary artery disease ... Abdominal obesity is associated with specific metabolic abnormalities that ...

| PowerPoint PPT presentation | free to view

New Pharmacotherapies for Assisting Smokers in Their Cessation Efforts- Update PowerPoint PPT Presentation

New Pharmacotherapies for Assisting Smokers in Their Cessation Efforts- Update - Title: PowerPoint Presentation Author: Anne Quito Last modified by: Aed_User Created Date: 11/16/2005 4:14:20 PM Document presentation format: On-screen Show

Title: PowerPoint Presentation Author: Anne Quito Last modified by: Aed_User Created Date: 11/16/2005 4:14:20 PM Document presentation format: On-screen Show

| PowerPoint PPT presentation | free to download

Scientific Writing, HRP 214 Weekly Quiz PowerPoint PPT Presentation

Scientific Writing, HRP 214 Weekly Quiz - Title: Science Writing 7 Author: Kristin Cobb Last modified by: Kristin Created Date: 5/17/1996 12:08:30 PM Document presentation format: Letter Paper (8.5x11 in)

Title: Science Writing 7 Author: Kristin Cobb Last modified by: Kristin Created Date: 5/17/1996 12:08:30 PM Document presentation format: Letter Paper (8.5x11 in)

| PowerPoint PPT presentation | free to download

Diabetologie: Was ist neu seit 2005? PowerPoint PPT Presentation

Diabetologie: Was ist neu seit 2005? - Diabetologie: Was ist neu seit 2005? https://www2.univadis.de/academia/?section=symposien&study=symp00022

Diabetologie: Was ist neu seit 2005? https://www2.univadis.de/academia/?section=symposien&study=symp00022

| PowerPoint PPT presentation | free to download

TISSU ADIPEUX VISCERAL CIBL UNE NOUVELLE OPTION DE LA BITHERAPIE ORALE - TISSU ADIPEUX VISCERAL CIBL UNE NOUVELLE OPTION DE LA BITHERAPIE ORALE

TISSU ADIPEUX VISCERAL CIBL UNE NOUVELLE OPTION DE LA BITHERAPIE ORALE

| PowerPoint PPT presentation | free to download

How To Become Slim Again With Natural Supplements? PowerPoint PPT Presentation

How To Become Slim Again With Natural Supplements? - This Power Point Presentation describes about How To Become Slim Again With Natural Supplements.

This Power Point Presentation describes about How To Become Slim Again With Natural Supplements.

| PowerPoint PPT presentation | free to download

Diapositiva 1 PowerPoint PPT Presentation

Diapositiva 1 - Cannabinoides e inflamaci n intestinal ANANDAMIDA ( concentraci n) CB-1 CB-2 TRPV-1 Inflamaci n Contractilidad Hipersecreci n Cicatrizaci n

Cannabinoides e inflamaci n intestinal ANANDAMIDA ( concentraci n) CB-1 CB-2 TRPV-1 Inflamaci n Contractilidad Hipersecreci n Cicatrizaci n

| PowerPoint PPT presentation | free to download

Obesidad - Cruz Contreras (Luis Humberto) Estado de exceso de masa de tejido adiposo IMC (kg/m2), antropometr a (pliegues cut neos, densitometr a, CT, MRI q.

Cruz Contreras (Luis Humberto) Estado de exceso de masa de tejido adiposo IMC (kg/m2), antropometr a (pliegues cut neos, densitometr a, CT, MRI q.

| PowerPoint PPT presentation | free to download

Molecular and Clinical Nutrition Course PowerPoint PPT Presentation

Molecular and Clinical Nutrition Course - Calorie intake must be less than caloric ... Calorie Controlled portions. ... Over-The Counter Orlistat Alli Rossner S et al. Obes Res 8(1):49-60, 2000. ...

Calorie intake must be less than caloric ... Calorie Controlled portions. ... Over-The Counter Orlistat Alli Rossner S et al. Obes Res 8(1):49-60, 2000. ...

| PowerPoint PPT presentation | free to view

Dr Nicki Mazey PowerPoint PPT Presentation

Dr Nicki Mazey - Obesity Primary Care Management Dr Nicki Mazey Introduction Predisposing factors Co-morbidities Managing Obesity in primary care Sleep apnoea/Binge eating Tools ...

Obesity Primary Care Management Dr Nicki Mazey Introduction Predisposing factors Co-morbidities Managing Obesity in primary care Sleep apnoea/Binge eating Tools ...

| PowerPoint PPT presentation | free to view

New Pharmacotherapies for Assisting Smokers in Their Cessation Efforts PowerPoint PPT Presentation

New Pharmacotherapies for Assisting Smokers in Their Cessation Efforts - Weight gain in the 20 mg group was 0.4 kg for 12 weeks versus 3.6 kg for placebo ... May be sought after by smokers who want to quit but don't want to gain weight ...

Weight gain in the 20 mg group was 0.4 kg for 12 weeks versus 3.6 kg for placebo ... May be sought after by smokers who want to quit but don't want to gain weight ...

| PowerPoint PPT presentation | free to download

Medicines for the Treatment of Obesity PowerPoint PPT Presentation

Medicines for the Treatment of Obesity - Medicines for the Treatment of Obesity But Doc, isn t there a pill I can take? Joanna Ruchala, MD Outline Case Presentation Definition, Prevalence ...

Medicines for the Treatment of Obesity But Doc, isn t there a pill I can take? Joanna Ruchala, MD Outline Case Presentation Definition, Prevalence ...

| PowerPoint PPT presentation | free to view

Women @ Heart The link between visceral fat and Athersclerosis PowerPoint PPT Presentation

Women @ Heart The link between visceral fat and Athersclerosis - Women @ Heart The link between visceral fat and Athersclerosis By Ashraf Reda MD Prof and Head of Cardiology Dep Menofia university Effect of plasma FFA Lipid profile ...

Women @ Heart The link between visceral fat and Athersclerosis By Ashraf Reda MD Prof and Head of Cardiology Dep Menofia university Effect of plasma FFA Lipid profile ...

| PowerPoint PPT presentation | free to download

CVD Critical Pathways Group 2006 Teleconferences PowerPoint PPT Presentation

CVD Critical Pathways Group 2006 Teleconferences - The Network for Continuing Medical Education requires that ... Phentermine. Year Approved. Approved Use. DEA Schedule. 1997. Long term. IV. 1973. Short term ...

The Network for Continuing Medical Education requires that ... Phentermine. Year Approved. Approved Use. DEA Schedule. 1997. Long term. IV. 1973. Short term ...

| PowerPoint PPT presentation | free to view

RIOLipids: Treatment effect on lipids PowerPoint PPT Presentation

RIOLipids: Treatment effect on lipids - RIO-Lipids: Treatment effect on lipids. Despr s J-P et al. N Engl J Med. 2005;353:2121-34. ... Intent-to-treat population *P 0.001 vs placebo. No significant ...

RIO-Lipids: Treatment effect on lipids. Despr s J-P et al. N Engl J Med. 2005;353:2121-34. ... Intent-to-treat population *P 0.001 vs placebo. No significant ...

| PowerPoint PPT presentation | free to view

AntiObesity Medication PowerPoint PPT Presentation

AntiObesity Medication - Should not be prescribed to children in General Practice if all other advice ... Benefit in taking BP and blood for fasting glc and lipid profile ...

Should not be prescribed to children in General Practice if all other advice ... Benefit in taking BP and blood for fasting glc and lipid profile ...

| PowerPoint PPT presentation | free to view

Obesity Pharmacological treatments PowerPoint PPT Presentation

Obesity Pharmacological treatments - A low energy,low fat diet is the most effective lifestyle intervention for weight loss ... Flatulence. Fatty oily stools. Faecal urgency ...

A low energy,low fat diet is the most effective lifestyle intervention for weight loss ... Flatulence. Fatty oily stools. Faecal urgency ...

| PowerPoint PPT presentation | free to view

Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology PowerPoint PPT Presentation

Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology - Abdominal obesity is more highly correlated with metabolic risk factors than is ... Obesity / weight management: low fat high fiber diet resulting in 500-1000 ...

Abdominal obesity is more highly correlated with metabolic risk factors than is ... Obesity / weight management: low fat high fiber diet resulting in 500-1000 ...

| PowerPoint PPT presentation | free to view

Anorexia, Bulimia and the Skinny on Fat J. Randle Adair, D.O., Ph.D. Diplomate, American Board of Internal Medicine Certified, American Society of Addiction Medicine - The Architecture: The Synapse from Mihic & Harris, 1997 The Adolescent Alcoholic Male ... emotional expression Social introversion Body image disturbances ...

The Architecture: The Synapse from Mihic & Harris, 1997 The Adolescent Alcoholic Male ... emotional expression Social introversion Body image disturbances ...

| PowerPoint PPT presentation | free to download

Largest Single Cost for Medicare PowerPoint PPT Presentation

Largest Single Cost for Medicare - Charles P. O'Brien, MD, PhD. University of Pennsylvania ... Wade Berrettini A. Thomas McLellan. John Cacciola David Metzger. Anna Rose Childress David Oslin ...

Charles P. O'Brien, MD, PhD. University of Pennsylvania ... Wade Berrettini A. Thomas McLellan. John Cacciola David Metzger. Anna Rose Childress David Oslin ...

| PowerPoint PPT presentation | free to view